2014 February

Michal was selected for the semi-finals of the OneStart Europe 2014 business plan competition with the proposal Cytotect 3D. The proposal described a novel device for improved drug screening.

Alvaro gave a talk titled “Hierarchical bioengineering: from dynamic self-assembly to 3D patterning” at the International Conference on Nanotechnology in Medicine at the Royal Free Hospital, University College London, UK.

The Mata Lab received a one year extension for the project BIOCART funded by the AO Foundation. This project is part of an international effort led by six world-renowned laboratories to develop a novel therapy for articular cartilage leisons.